The Conversation (0)
Marketwired reports that the pharmaceutical excipients market — byproducts such as petrochemicals, carbohydrates, and polymers — is expected to be worth $7.356 billion by 2018.
Marketwired reports that the pharmaceutical excipients market — byproducts such as petrochemicals, carbohydrates, and polymers — is expected to be worth $7.356 billion by 2018.
As quoted in the press release:
The Pharmaceutical Excipients Market has experienced extensive growth in the past few years, mainly attributed to the various advancements in the pharmaceutical industry related to drug delivery technologies. The increasing use of generics and the emergence of new excipients are factors that further propel the growth of this market. However, the increasing cost of raw materials, stringent regulatory requirements and quality specifications, and the increasingly competitive environment are factors that inhibit the growth of the market to a certain extent.